Drug Patent Expirations for the Week of October 9, 2022
October 10, 2022 Comments Off on Drug Patent Expirations for the Week of October 9, 2022 Posted in: Uncategorized
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for the Week of October 9, 2022 appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.
Drug Patent Expirations for the Week of October 9, 2022
Comments Off on Drug Patent Expirations for the Week of October 9, 2022 Posted in: Uncategorized
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for the Week of October 9, 2022 appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.